 |
|
Pathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection
Lawrence E. Harrison, MD;
Paul B. Gaudin, MD;
Murray F. Brennan, MD
Arch Surg. 1999;134:181-185.
Objective To identify the pathologic features of prognostic significance in patients with resectable adrenocortical carcinomas.
Design Retrospective review.
Setting Tertiary referral center.
Patients Review of the Memorial Sloan-Kettering Cancer Center prospective adrenocortical carcinoma database from 1986 through 1996 identified 46 patients who underwent curative adrenalectomy for primary disease. All cases were reviewed by a single pathologist and each primary tumor was characterized by 16 separate pathologic parameters.
Main Outcome Measure Overall survival rates in the patient population.
Results The 5-year overall survival rate for the entire cohort was 36% (median survival rate, 28 months). Of the pathologic factors analyzed, tumor size, number of mitotic figures, and the presence of intratumoral hemorrhage were independent prognostic factors. Patients presenting with primary tumors larger than 12 cm (n=30) had a worse outcome compared with those with smaller tumors (n=16) (5-year survival rate: 53% vs 22%, P<.05). Mitotic count ( 6 per 10 high-power fields) was a negative prognostic feature (n=15) with a 5-year survival rate of 13% vs 51% for 0 to 6 mitotic figures per 10 high-power fields (n=31, P<.05). Intratumoral hemorrhage (n=23) was also a negative prognostic factor compared with no evidence of intratumoral hemorrhage (n=23) (5-year survival rate, 53% vs 22%, P<.05). Overall survival rates were also calculated based on the number of pathologic risk factors. Patients with no risk factors had an 83% 5-year survival rate, which decreased to 42% with 1 factor, 33% with 2 factors, and 0% with all 3 risk factors.
Conclusions Tumor size, hemorrhage, and mitotic count correlate with survival rates for patients undergoing curative resection. Based on these pathologic factors, adrenocortical carcinomas may be divided into low- and high-risk groups.
From the Division of Surgical Oncology, Department of Surgery, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark (Dr Harrison); and the Departments of Pathology (Dr Gaudin) and Surgery (Dr Brennan), Memorial Sloan-Kettering Cancer Center, New York, NY.
RELATED ARTICLE
Invited Critique: Pathologic Features of Prognostic Significance for Adrenocortical Carcinoma After Curative Resection
Andrew Saxe
Arch Surg. 1999;134(2):185.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Pathological and molecular features of adrenocortical carcinoma: an update
Volante et al.
J. Clin. Pathol. 2008;61:787-793.
ABSTRACT
| FULL TEXT
Extremely long survival in six patients despite recurrent and metastatic adrenal carcinoma.
Hermsen et al.
Eur J Endocrinol 2008;158:911-919.
ABSTRACT
| FULL TEXT
Surgical Outcome of Stage III and IV Adrenocortical Carcinoma
Ohwada et al.
Jpn J Clin Oncol 2007;0:hyl127v1-6.
ABSTRACT
| FULL TEXT
Prognostic Parameters of Metastatic Adrenocortical Carcinoma
Assie et al.
J. Clin. Endocrinol. Metab. 2007;92:148-154.
ABSTRACT
| FULL TEXT
Adrenocortical Carcinoma: Clinical Update
Allolio and Fassnacht
J. Clin. Endocrinol. Metab. 2006;91:2027-2037.
ABSTRACT
| FULL TEXT
Prevalence of HLA-DRB1 Genotype and Altered Fas/Fas Ligand Expression in Adrenocortical Carcinoma
Wolkersdorfer et al.
J. Clin. Endocrinol. Metab. 2005;90:1768-1774.
ABSTRACT
| FULL TEXT
High Expression of Neuropeptide Y Receptors in Tumors of the Human Adrenal Gland and Extra-Adrenal Paraganglia
Korner et al.
Clin. Cancer Res. 2004;10:8426-8433.
ABSTRACT
| FULL TEXT
The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management
Mansmann et al.
Endocr. Rev. 2004;25:309-340.
ABSTRACT
| FULL TEXT
Metastasis to the Adrenal Gland: The Emerging Role of Laparoscopic Surgery
Sarela et al.
Ann. Surg. Oncol. 2003;10:1191-1196.
ABSTRACT
| FULL TEXT
Laparoscopic Resection of Large Adrenal Tumors
MacGillivray et al.
Ann. Surg. Oncol. 2002;9:480-485.
ABSTRACT
| FULL TEXT
Adrenocortical Carcinoma: Clinical, Morphologic, and Molecular Characterization
Stojadinovic et al.
JCO 2002;20:941-950.
ABSTRACT
| FULL TEXT
|
